Eftychia Chatziioannou

Deep learning-based scoring of tumour-infiltrating lymphocytes is prognostic in primary melanoma and predictive to PD-1 checkpoint inhibition in melanoma metastases

Eftychia Chatziioannou, Jana Roßner, Thazin New Aung et al. · EBioMedicine · 2023 · 44 citations · Full text

Identification of stage I/II melanoma patients at high risk for recurrence using a model combining clinicopathologic factors with gene expression profiling (CP-GEP)

Teresa Amaral, Tobias Sinnberg, Eftychia Chatziioannou et al. · European Journal of Cancer · 2022 · 33 citations · Full text

Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy

Eftychia Chatziioannou, Ulrike Leiter, Ioannis Thomas et al. · American Journal of Clinical Dermatology · 2023 · 13 citations · Full text

PARP Inhibitors Effectively Reduce MAPK Inhibitor Resistant Melanoma Cell Growth and Synergize with MAPK Inhibitors through a Synthetic Lethal Interaction <i>In Vitro</i> and <i>In Vivo</i>

Lisa Marie Fröhlich, Heike Niessner, Birgit Sauer et al. · Cancer Research Communications · 2023 · 13 citations · Full text

Risk stratification using the Merlin Assay (CP-GEP) in an independent cohort of 930 patients with clinical stage I/II melanoma who did not undergo sentinel lymph node biopsy

Teresa Amaral, Eftychia Chatziioannou, Alica Nuebling et al. · European Journal of Cancer · 2025 · 10 citations · Full text